Literature DB >> 10648385

Adaptor proteins CRK and CRKL associate with the serine/threonine protein kinase GCKR promoting GCKR and SAPK activation.

C S Shi1, J Tuscano, J H Kehrl.   

Abstract

STE20-related kinases play significant regulatory roles in a range of cellular responses to environmental stimuli. GCKR (also referred to as KHS1) is a serine/threonine protein kinase that has an STE20-like protein kinase domain and that stimulates the stress-activated protein kinase (SAPK, also referred to as Jun kinase or JNK) pathway. GCKR has a large C-terminal regulatory domain that provides sites for interactions with other proteins. Adaptor proteins mediate the interactions between signaling molecules. In this study we showed that the adaptor proteins Crk and CrkL associated with GCKR. When Crk-I, Crk-II, or CrkL was transiently expressed in HEK 293T cells along with GCKR, each coimmunoprecipitated with GCKR. Furthermore, in the Bcr-Abl transformed cell line, K562 endogenous GCKR and CrkL coimmunoprecipitated, indicating a constitutive association. Detection of the CrkL-GCKR interaction required the SH3 domains of CrkL and 2 regions in GCKR-1 between amino acids 387 and 395 that contains a consensus SH3 binding motif and the other between amino acids 599 and 696. Crk or CrkL overexpression increased GCKR catalytic activity. A dominant negative form of Ras abolished Crk- or CrkL-induced GCKR activation, suggesting a dependence on Ras activation for their activation of GCKR. Finally, we showed impairment of the known ability of CrkL to activate the SAPK pathway by a catalytically inactive form of GCKR or by a GCKR antisense construct. Thus, GCKR associates with other proteins through interactions mediated by SH2/SH3 adaptor proteins, which can lead to GCKR and SAPK activation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10648385

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  9 in total

1.  Caspase-independent apoptosis induction of quorum-sensing autoinducer analogs against chronic myeloid leukemia K562.

Authors:  Masaharu Hazawa; Michiko Kudo; Toshihiro Iwata; Kazuki Saito; Kenji Takahashi; Jun Igarashi; Hiroaki Suga; Ikuo Kashiwakura
Journal:  Invest New Drugs       Date:  2011-01-05       Impact factor: 3.850

2.  A Cross-Linking-Aided Immunoprecipitation/Mass Spectrometry Workflow Reveals Extensive Intracellular Trafficking in Time-Resolved, Signal-Dependent Epidermal Growth Factor Receptor Proteome.

Authors:  Yue Chen; Mei Leng; Yankun Gao; Dongdong Zhan; Jong Min Choi; Lei Song; Kai Li; Xia Xia; Chunchao Zhang; Mingwei Liu; Shuhui Ji; Antrix Jain; Alexander B Saltzman; Anna Malovannaya; Jun Qin; Sung Yun Jung; Yi Wang
Journal:  J Proteome Res       Date:  2019-09-09       Impact factor: 4.466

3.  MAP4K Interactome Reveals STRN4 as a Key STRIPAK Complex Component in Hippo Pathway Regulation.

Authors:  Gayoung Seo; Han Han; Rebecca Elizabeth Vargas; Bing Yang; Xu Li; Wenqi Wang
Journal:  Cell Rep       Date:  2020-07-07       Impact factor: 9.423

4.  The -822G/A polymorphism in the promoter region of the MAP4K5 gene is associated with reduced risk of type 2 diabetes in Chinese Hans from Shanghai.

Authors:  Yanyun Gu; Tianhong Luo; Jian Yang; Di Zhang; Meng Dai; Weixia Jian; Sheng Zheng; Wenzhong Zhou; Weibin Zhou; Yixing Wu; Yun Liu; Youping Liu; Jiping Li; Xiaoyan Xie; Guo Li; Min Luo
Journal:  J Hum Genet       Date:  2006-05-13       Impact factor: 3.172

Review 5.  Molecular biology of chronic myeloid leukemia.

Authors:  Y Maru
Journal:  Int J Hematol       Date:  2001-04       Impact factor: 2.490

Review 6.  HDAC6-an Emerging Target Against Chronic Myeloid Leukemia?

Authors:  Hélène Losson; Michael Schnekenburger; Mario Dicato; Marc Diederich
Journal:  Cancers (Basel)       Date:  2020-01-29       Impact factor: 6.639

7.  Why Do Muse Stem Cells Present an Enduring Stress Capacity? Hints from a Comparative Proteome Analysis.

Authors:  Mustafa B Acar; Domenico Aprile; Serife Ayaz-Guner; Huseyin Guner; Coskun Tez; Giovanni Di Bernardo; Gianfranco Peluso; Servet Ozcan; Umberto Galderisi
Journal:  Int J Mol Sci       Date:  2021-02-19       Impact factor: 5.923

8.  PAK1 kinase promotes cell motility and invasiveness through CRK-II serine phosphorylation in non-small cell lung cancer cells.

Authors:  Matthew Rettig; Kenny Trinidad; G Pezeshkpour; Patrick Frost; Sherven Sharma; Farhad Moatamed; Fuyuhiko Tamanoi; Fariborz Mortazavi
Journal:  PLoS One       Date:  2012-07-27       Impact factor: 3.240

9.  Prognostic and Functional Significance of MAP4K5 in Pancreatic Cancer.

Authors:  Oliver H Wang; Nancy Azizian; Ming Guo; Michela Capello; Defeng Deng; Fenglin Zang; Jason Fry; Matthew H Katz; Jason B Fleming; Jeffrey E Lee; Robert A Wolff; Samir Hanash; Huamin Wang; Anirban Maitra
Journal:  PLoS One       Date:  2016-03-29       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.